Table 2.

Mean change in CVD risk factors among subjects enrolled for primary prevention of CVDs at 1 year follow up

S.No	CVD risk factor	N	Baseline	Post intervention	Mean change (95% CI)	% Change	t statistic	P valve	Cohen’s d
			Mean ± 1 SD	Mean ± 1SD
1.	Systolic BP (mmHg)
	Male	201	140.94 ± 17.51	128.16 ± 14.28	−12.78 (−15.41, −10.14)	−9.06	9.55	.01	0.79
	Female	159	136.57 ± 17.00	125.91 ± 11.83	−10.66 (−13.14,-8.18)	−7.80	8.49	.01	0.72
	Total	360	139.01 ± 17.40	127.16 ± 13.29	−11.84 (−13.67, −10.01)	−8.52	11.68	.01	0.76
2	Diastolic BP (mmHg)
	Male	201	88.49 ± 12.52	82.60 ± 9.16	−5.88 (−7.71,-4.05)	−6.65	6.33	.01	0.53
	Female	159	85.21 ± 10.29	80.48 ± 8.56	−4.72 (−6.48,-2.97)	−5.55	5.31	.01	0.49
	Total	360	87.04 ± 11.69	81.66 ± 8.95	−5.38 (−6.65, −4.09)	− 6.18	7.52	.01	0.51
3.	RBS (mg/dl)
	Male	148	139.16 ± 66.31	128.42 ± 42.93	−10.73 (−20.47,-1.00)	−7.71	2.18	.03	0.19
	Female	116	148.73 ± 66.57	135.38 ± 47.10	−13.34 (−24.25,-2.43)	−8.97	2.42	.01	0.23
	Total	264	143.36 ± 66.47	131.48 ± 44.86	−11.88 (−19.10, −4.66,)	−8.28	2.68	.01	0.20
4.	FTND score	28	5.35 ± 2.46	2.64 ± 1.98	2.71 (1.89,3.53)	50.65	6.82	<.01	1.2

Cohen’s d: small (0.2), medium (0.5) and large (0.8)